Literature DB >> 20369789

NMR and gas chromatography studies of lyophilized human brain tumors.

Ryszard Marszałek1, Maciej Pisklak, Wiesław Jankowski, Jacek Łukaszkiewicz, Dariusz Horsztyński, Iwona Wawer.   

Abstract

1H HR MAS (high resolution magic angle spinning) NMR is a promising tool in the in vitro characterisation of brain tumors. Brain tissue samples were collected from patients with intracranial tumors during surgery, frozen and lyophilized. The analysis of solid samples was performed by high-speed rotation (33 kHz) H MAS NMR. The most intense resonances arise from lipids (methylene mid-chain and methyl carbons of fatty acids). 1H MAS spectra obtained from the same histological type of brain tumors are similar; spectra of glioblastomas were different from those of meningiomas. 1H and 13C NMR solution spectra of lipid extracts confirmed the presence of aliphatic chains fatty acids and cholesterol as major constituents. Biochemical information on liberated fatty acid composition was obtained by gas-chromatography (GC). The glioma content of the linoleic acid (18:2n6) was found to be greater, whereas the level of docosahexaenoic acid (22:6n3) was significantly reduced.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20369789

Source DB:  PubMed          Journal:  Acta Pol Pharm        ISSN: 0001-6837            Impact factor:   0.330


  3 in total

1.  Brain fatty acid-binding protein and omega-3/omega-6 fatty acids: mechanistic insight into malignant glioma cell migration.

Authors:  Raja Mita; Michael J Beaulieu; Catherine Field; Roseline Godbout
Journal:  J Biol Chem       Date:  2010-09-12       Impact factor: 5.157

Review 2.  Interaction of brain fatty acid-binding protein with the polyunsaturated fatty acid environment as a potential determinant of poor prognosis in malignant glioma.

Authors:  Marwa E Elsherbiny; Marwan Emara; Roseline Godbout
Journal:  Prog Lipid Res       Date:  2013-08-24       Impact factor: 16.195

3.  Fatty acid desaturase 1 (FADS1) is a cancer marker for patient survival and a potential novel target for precision cancer treatment.

Authors:  Gioia Heravi; Hyejeong Jang; Xiaokun Wang; Ze Long; Zheyun Peng; Seongho Kim; Wanqing Liu
Journal:  Front Oncol       Date:  2022-08-15       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.